2024 Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among veteran patients with cutaneous melanoma. Daniel Y. Kim, Susan M. Swetter, Linden Huhmann, Matthew P. Dizon, Jacqueline M. Ferguson, Thomas F. Osborne, Allyson C. Spence, Amina Ziad, Nathanael Fillmore‡, Rebecca I. Hartman‡‡ Equal senior authorship Journal of the American Academy of Dermatology90(3), 620-623 U.S. Veterans and VA Data Retrospective Cohort Study Cutaneous Melanoma Immune Checkpoint Inhibitors BRAF/MEK Inhibitors
